SteadySharesSteadyShares
The market
MarketsDiscover
Follow the money
Smart MoneyPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Pre-market
SteadySharesMarketsDiscoverSmart MoneyMy WealthPoliticiansCryptoNews
/
DiscoverIQV
HealthcareNYSEUSD

IQVIA Holdings

$001234567890012345678900123456789.0012345678900123456789+17.5%
52w low (est.) $164.18$269.43 52w high (est.)
Peers
Market data
Market cap
$34.69B
52-week range
$154.50 – $247.05
Beta (vs market)
1.20
Sector
Healthcare
Valuation
P/E ratio
25.9x
DCF fair value
$249.24
Margin of safety
+18.4%
Forward P/E
14.7x
PEG ratio
0.82
Quality & efficiency
Moat score
49/100
Return on equity
22.5%
Profit margin
8.3%
Debt / equity
2.55
Growth & analysts
Revenue growth (YoY)
+8.4%
Analyst target
$229.63
Target upside
+9.1%
Analysts covering
19

About IQVIA Holdings

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with Kexing Biopharm Co., Ltd. for biosimilar development. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. is based in Durham, North Carolina.

Valuation

ValueGrowthProfitHealthIncome32QUALITY
Overall Rating
55
Buy
Buy
Moat Score49
DCF Intrinsic Value
$249.24+18.4% upside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
$34.69B
P/E Ratio
25.9
Dividend Yield
0.00%
Revenue Growth
+8.4%
Profit Margin
8.3%
ROE
22.5%
Debt / Equity
2.55
Beta
1.20
vs Healthcare sector:P/E 26 vs 28 · cheaperMoat 49 vs 7Yield 0.00% vs 0.3%

Statistics

Similar Stocks · Healthcare

LLY73
$920.00+0.7%
AZN.L72
£105.20+0.6%
UNH71
$492.10+1.6%
JNJ70
$146.20-0.2%

Latest News · IQV